HJT Everywhere: Huasun Demonstrates Flexible PV Integration from Balconies to Electric Vehicles at SNEC 2025
SHANGHAI, June 18, 2025 /PRNewswire/ -- Huasun Energy, the world's leading heterojunction (HJT) solar technology provider, launched three astonishing new products to push the limits of solar application on the first day of SNEC PV Power Expo 2025 in Shanghai, including aesthetic balcony solar products, vehicle integrated photovoltaic (VIPV) solution and anti-glare PV modules.
Urban spaces often present multiple challenges for traditional rooftop solar. Huasun's new colorful balcony solar system meets this need with a compact, plug-and-play design tailored for apartments and high-density housing. It features pre-assembled brackets, vibrant HJT modules, and built-in microinverters—allowing residents to install their own clean power within only 15 minutes.
As electric mobility accelerates, so does the need for extended range and off-grid charging options. Huasun's VIPV solution addresses this by integrating HJT solar modules directly into the vehicle surface. Featuring cambered HJT modules with 0BB design and curved glass, the system generates over 1.2 kWh of electricity per day—sufficient to support up to 25 km of additional driving range. Over the course of a year, that translates to approximately 2,000 km of clean, solar-powered travel—ideal for remote, off-grid, or low-infrastructure environments.
Where solar installation used to be restricted by glare concerns—particularly near highways, railways and airports—Huasun's anti-glare modules now offer a breakthrough solution. Engineered with specialized optical treatment on the module surface, these HJT modules minimize glare while maintaining high power output—ensuring coexistence of superior safety and performance.
As the world's largest HJT manufacturer, Huasun Energy keeps leading in the R&D and large-scale production of high-efficiency n-type silicon-based HJT ingots, wafers, cells, and modules. By continuously adapting advanced HJT technologies to real-world scenarios, Huasun is driving the broader adoption of solar energy across modern life.
Website: www.huasunsolar.com
Follow "HUASUN HJT" on LinkedIn for more heterojunction updates.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/hjt-everywhere-huasun-demonstrates-flexible-pv-integration-from-balconies-to-electric-vehicles-at-snec-2025-302484991.html
SOURCE Huasun Energy
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
31 minutes ago
- Entrepreneur
Steptrade Capital Announces First Close of INR 1,000 Cr Microcap Fund SRF-II
The fund aims to invest in India's listed and unlisted small and microcap businesses. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Steptrade Capital has announced the first close of its third Alternative Investment Fund (AIF), Steptrade Revolution Fund-II (SRF-II), with a total deployment target of INR 1,000 crore. The fund aims to invest in India's listed and unlisted small and microcap enterprises, continuing Steptrade's sharp focus on underserved yet high-potential businesses. SRF-II builds on the legacy of Steptrade's earlier funds—the Chanakya Opportunities Fund and Steptrade Revolution Fund-I—which also targeted India's small business landscape. The new fund will focus on critical sectors such as renewables, defence, waste management, and infrastructure. "This early close is a strong vote of confidence from our investors," said CA Kresha Gupta, Director and Fund Manager at Steptrade Capital. "It reflects the strength of our investment philosophy—rooted in bottom-up research, market depth, and a clear focus on value creation in sectors that matter." Operating across all SEBI-regulated investment formats—AIF Categories I, II, and III, Portfolio Management Services (PMS), and Foreign Portfolio Investment (FPI)—Steptrade now offers one of India's most comprehensive platforms for SME investing. "In microcap investing, timing and structure matter as much as the idea itself," added Ankush Jain, CFA, Director and Fund Manager. "SRF-II reflects a disciplined approach where every allocation is backed by deep research, clear valuation logic, and a focus on protecting downside while capturing structural upside." Steptrade continues to position itself as a thought leader in SME investments, with sustainability and innovation at the core of its strategies. With SRF-II, the firm deepens its commitment to backing India's next generation of high-growth enterprises.
Entrepreneur
32 minutes ago
- Entrepreneur
Institutional Investors Bet Big on Scalable Climate Solutions
India's clean-tech and EV investment landscape is rapidly evolving, from strong early stage funding to a deep focus on commercial scale and infrastructure, backed by robust frameworks, investors are not financing end-to-end solutions. Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. India's clean-tech and EV investment landscape is rapidly evolving, from strong early stage funding to a deep focus on commercial scale and infrastructure, backed by robust frameworks, investors are not financing end-to-end solutions. According to Grip Invest, 2024 saw a significant rise in funding, attracting USD 564 million, a 37 per cent increase. Sustainable mobility (EV, OEMs, shared mobility, and batteries) accounted for over 70 per cent of funding, close to USD 220 million in Q2. Coming to institutional investment commitments, the United Kingdom's investment arm, British International Investment (BII) deployed USD 22.5 million in December 2024 into India's EV ecosystem, with a USD 15 million fund towards Everest Fleet and TI Clean Mobolity and a USD 3.5 million to Vecmocon, bringing its total commitment in the EV sector to USD 328 million. Schemes like Production-Linked Incentives (PLIs), which gave approximately USD 2.1 billion for advanced cell chemistry/batteries, USD 2.3 billion for solar panels, FAME II/III allocated $1.3 B through 2024 with another USD 300 million for FY 25. According to Crisil, India's green investments are projected to grow fivefold to INR 31 Lakh Crore, which is approximately USD 376 billion by 2030. Tarun Kapoor, Adviser to the PMO said this at a FICCI conference last year, "On 2‑wheelers, we should have much higher targets and a complete replacement is what we have to look for. On 4‑wheelers, government is fully supportive and there is a need to look at GST on batteries and charging stations," expressing ambition for full electrification of smaller EV segments. Tax incentives and import reductions seek to correct the heavy dependency on imported EV components . However, Orf research highlights a USD 44 billion per year climate funding gap and that current public-private investment falls well short of the USD 385 billion required by 2030. Vasudha Madhavan, Founder and CEO, Ostara Advisors said that the firm is observing a growing shift toward the broader climate tech ecosystem, which now encompasses not just renewables and solar energy, including rooftop solar, but also areas like industrial decarbonization, clean logistics, and energy-efficient warehousing. "Investor interest is expanding beyond the earlier EV-centric focus to include a diverse range of sectors contributing to decarbonization. However, the key challenge lies in ensuring these companies have strong unit economics and a clear path to profitability and scale. Additionally, there is increasing investor interest in niche segments within the EV space, including EV OEMs and ecosystem enablers such as financing solutions. There's a notable rise in attention from global investors, particularly from APAC, the Middle East, and other regions. We're also seeing the emergence of India-domiciled climate funds aimed at providing growth capital," said Madhavan, As private capital flows into Indian climate tech, we anticipate significant momentum toward building profitable, scalable businesses,driven by the immense opportunity the Indian market presents, added Madhavan. The events signal a shift, a shift in investor confidence that is transitioning from speculative to strategic scale plays, laying the groundwork for India's green technology future.
Yahoo
an hour ago
- Yahoo
2 Top Stocks to Buy With Less Than $30
Pfizer's deep product pipeline, cost-cutting efforts, and dividend make the stock attractive. Adyen's shares look expensive for all the right reasons, and it should still deliver strong returns. 10 stocks we like better than Pfizer › Though wealthy and successful investors garner much attention on Wall Street, equity markets are accessible to the average person. That's one of the great things about investing in stocks. Even with $30, it's possible to buy stock in top companies that are likely to perform well over the long run -- and we're not talking about fractional shares, either. Let's consider two stocks that are trading for less than $30 per share but are great picks for long-term investors: Pfizer (NYSE: PFE) and Adyen (OTC: ADYE.Y). Pfizer has experienced subpar performances over the past three years, primarily due to unimpressive financial results. The company isn't out of the woods, either. It's facing some important patent cliffs, including one for its anticoagulant Eliquis, which will lose exclusivity in the U.S. by the end of the decade. Even with these challenges, the sell-off Pfizer has experienced in recent years may have created a brilliant opportunity to purchase its shares on the dip. The stock's forward price-to-earnings (P/E) was recently 8.3, compared to the healthcare industry's average of 16.2. Some might argue that Pfizer still isn't attractive because its prospects don't look bright. But partly thanks to its success in the coronavirus space -- and its generating unprecedented revenue for a biopharma company -- it has significantly beefed up its pipeline in recent years. Pfizer is still at it. It recently licensed a promising investigational cancer drug from China-based 3SBio called SSGJ-707. This medicine is a bispecific antibody, an area of the cancer market that is catching fire, and the pharmaceutical giant wants a piece of it. Pfizer's oncology pipeline appears particularly robust, but it also boasts promising candidates in other areas. It has more than 100 programs in total, so the company should successfully replenish its portfolio. Meanwhile, Pfizer has successfully reduced its expenses and remains engaged in cost-cutting initiatives that will further boost the bottom line. There are other reasons to invest in the company, including its dividend. Pfizer's poor performance in recent years has pushed its current yield up to a juicy 7%, and the company has increased its payouts by 62% in the past decade. The stock might not recover overnight, but for about $26 per share, Pfizer is a top pick for long-term, income-oriented investors. Adyen is a fintech leader that offers payment processing, payment gateways, and risk management services on a single, integrated platform. It is especially appealing to multinational companies that would otherwise have to deal with different providers for each of those needs in different regions. Adyen's ecosystem significantly simplifies things for its clients. That's why it has attracted the business of some major corporations, including Spotify Technology, Uber Technologies, and Microsoft. That's also why Adyen's revenue remains strong. Last year, the Netherlands-based company reported about 2 billion euros in revenue (about $2.3 billion), up 23% year over year, on 1.3 trillion euros ($1.5 trillion) in processed volume, which grew 33% compared to the year-ago period. Net income was 925.2 million euros ($1.1 billion), up 32% compared to 2023. Adyen has performed extremely well over the past year, thanks to its excellent results. However, its shares are becoming expensive; the forward P/E is around 47. While that means the stock could be somewhat volatile in the short term, the company's long-term prospects look attractive due to its wide moat and the industry's direction. Adyen benefits from switching costs -- its clients can't easily switch payment providers without risking disruption to their day-to-day activities. Elsewhere, Adyen -- which has a well-established business in Europe -- has been making a push in regions such as North America. It has only begun to scratch the surface of its opportunities in the U.S., where, as it points out, it only has a single-digit market share. Adyen won over major clients in Europe because of its superior offerings. It should do the same in the U.S., a less mature market for the company, but a significant one since it remains the world's single largest economy in terms of gross domestic product. So you can expect the stock to continue delivering superior returns over the long term, even if it experiences some short-term volatility. As of this writing, Adyen's shares are trading for a little under $20 apiece. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,821!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $886,880!* Now, it's worth noting Stock Advisor's total average return is 791% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Adyen, Microsoft, Pfizer, Spotify Technology, and Uber Technologies. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. 2 Top Stocks to Buy With Less Than $30 was originally published by The Motley Fool Sign in to access your portfolio
